Attila Pethoe-Schramm

Low immunogenicity of tocilizumab in patients with rheumatoid arthritis

Gerd R Burmester, Ernest Choy, Alan Kivitz et al. · Annals of the Rheumatic Diseases · 2016 · 102 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Incidence of Gastrointestinal Perforations in Patients with Rheumatoid Arthritis Treated with Tocilizumab from Clinical Trial, Postmarketing, and Real-World Data Sources

Sharareh Monemi, Erhan Berber, Khaled Sarsour et al. · Rheumatology and Therapy · 2016 · 43 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

Effectiveness of biologic and non-biologic antirheumatic drugs on anaemia markers in 153,788 patients with rheumatoid arthritis: New evidence from real-world data

Sanjoy K. Paul, Olga Montvida, Jennie H. Best et al. · Seminars in Arthritis and Rheumatism · 2017 · 24 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Initiating tocilizumab, with or without methotrexate, compared with starting methotrexate with prednisone within step-up treatment strategies in early rheumatoid arthritis: an indirect comparison of effectiveness and safety of the U-Act-Early and CAMERA-II treat-to-target trials

Maxime M. A. Verhoeven, Marjolein JH de Hair, Janneke Tekstra et al. · Annals of the Rheumatic Diseases · 2019 · 23 citations

Medicine, Pharmacology, Pharmacotherapy +14

Giant cell arteritis treatment patterns and rates of serious infections

Sara K. Tedeschi, Yinzhu Jin, Seanna Vine et al. · Clinical and Experimental Rheumatology · 2021 · 14 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +10